Selective Bibliography of Dr. John Jay Schneekloth Jr.
Chemical Biology Laboratory, NCI

Wednesday, February 25, 2025 

1. Herron L, Mondal K, Schneekloth JS, Jr., Tiwary P
   Inferring phase transitions and critical exponents from limited observations with thermodynamic maps
   Proceedings of the National Academy of Sciences of the United States of America 121 (52):e2321971121 Dec 24 2024
2. Chen S, Sibley CD, Latifi B, Balaratnam S, Dorn RS, Luptak A, Schneekloth JS, Jr., Prescher JA
   Bioorthogonal Cyclopropenones for Investigating RNA Structure
   ACS Chemical Biology 19 (12):2406-2411 Dec 20 2024
3. Temme JS, Tan Z, Li M, Yang M, Wlodawer A, Huang X, Schneekloth JS, Jr., Gildersleeve JC
   Insights into biofilm architecture and maturation enable improved clinical strategies for exopolysaccharide-targeting therapeutics
   Cell Chemical Biology 31 (12):2096-2111.e7 Dec 19 2024
4. Sidharthan V, Sibley CD, Dunne-Dombrink K, Yang M, Zahurancik WJ, Balaratnam S, Wilburn DB, Schneekloth JS, Jr., Gopalan V
   Use of a small molecule microarray screen to identify inhibitors of the catalytic RNA subunit of Methanobrevibacter smithii RNase P
   Nucleic Acids Research Dec 16 2024
5. Parmar S, Bume DD, Connelly CM, Boer RE, Prestwood PR, Wang Z, Labuhn H, Sinnadurai K, Feri A, Ouellet J, Homan P, Numata T, Schneekloth JS, Jr.
   Mechanistic analysis of Riboswitch Ligand interactions provides insights into pharmacological control over gene expression
   Nature Communications 15 (1):8173 Sep 17 2024
6. Prestwood PR, Yang M, Lewis GV, Balaratnam S, Yazdani K, Schneekloth JS, Jr.
   Competitive Microarray Screening Reveals Functional Ligands for the DHX15 RNA G-Quadruplex
   ACS Medicinal Chemistry Letters 15 (6):814-821 Jun 13 2024
7. Kim YY, Gryder BE, Sinniah R, Peach ML, Shern JF, Abdelmaksoud A, Pomella S, Woldemichael GM, Stanton BZ, Milewski D, Barchi JJ, Jr., Schneekloth JS, Jr., Chari R, Kowalczyk JT, Shenoy SR, Evans JR, Song YK, Wang C, Wen X, Chou HC, Gangalapudi V, Esposito D, Jones J, Procter L, O'Neill M, Jenkins LM, Tarasova NI, Wei JS, McMahon JB, O'Keefe BR, Hawley RG, Khan J
   KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion- positive rhabdomyosarcoma
   Nature Communications 15 (1):1703 Feb 24 2024
8. Yazdani K, Seshadri S, Tillo D, Yang M, Sibley CD, Vinson C, Schneekloth JS, Jr.
   Decoding complexity in biomolecular recognition of DNA i-motifs with microarrays
   Nucleic Acids Research 51 (22):12020-12030 Dec 11 2023
9. Li KS, Jordan D, Lin LY, McCarthy SE, Schneekloth JS, Jr., Yatsunyk LA
   Crystal Structure of an i-Motif from the HRAS Oncogene Promoter
   Angewandte Chemie International Edition 62 (26):e202301666 Jun 26 2023
10. Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Fullenkamp CR, Seshadri S, Holewinski RJ, Andresson T, Ferre-D'Amare AR, Incarnato D, Schneekloth JS, Jr.
    Investigating the NRAS 5' UTR as a target for small molecules
    Cell Chemical Biology 30 (6):643-657.e8 Jun 15 2023